
TechTalk: Benchmarking health & aging with proteomics
Friday, October 9 at 15:00 BST | 16:00 CEST | 10:00 EDT | 07:00 PDT
As the global population ages, researchers face a fundamental challenge: How do we measure healthy aging?
Chronological age alone provides limited insight into an individual's biological state, prompting growing interest in proteomic aging clocks and other proteomic signatures associated with biological aging, disease risk, and resilience.
Discover how proteomic approaches are advancing aging research, from whole-body aging to organ- and cellular-level aging signatures, and explore the measurement requirements needed to generate meaningful, high-quality data in this rapidly evolving field.
In this SelectScience® TechTalk, held in partnership with Illumina, you will:
- Understand the difference between chronological age and biological age.
- Explore landmark studies that uncovered proteomic aging clocks and aging signatures associated with disease risk and health outcomes at organ and cellular resolution.
- Learn the proteomic measurement requirements for aging research.
- Consider emerging research approaches to disentangle biological aging from disease progression.
Certificate of attendance
If you attend the live TechTalk, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes. If you view the on-demand TechTalk, you can request a certificate of attendance by emailing editor@selectscience.net.
TechTalk details
- Cost: Free to attend
- Location: Online
- Duration: 20 minutes
Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available.
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES.
Speakers

Who should attend?
- Biological aging
- Longevity
- Disease risk
- Biomarker discovery
- Translational proteomics
What will this webinar cover?
Join the TechTalk to get answers to these questions:
- How do chronological and biological age differ?
- Which proteomic signatures reveal biological aging?
- How are these signatures linked to disease risk and health outcomes?
- What proteomic measurements are required for aging research at organ and cellular resolution?
- How can emerging approaches distinguish biological aging from disease progression?
